Sacubitril + Valsartan Tablet

Sacubitril + Valsartan Tablet

Categories : Cardiovascular System

Product Packaging : 10x10 Blister

Product Composition : 24 mg + 26 mg / 49 mg + 51 mg / 97 mg + 103 mg

Send Message

Sacubitril + Valsartan Tablets are innovative cardiovascular medicines used for the treatment of chronic heart failure with reduced ejection fraction (HFrEF). The combination delivers dual therapeutic action by enhancing beneficial natriuretic peptides while blocking the harmful effects of angiotensin II, supporting improved cardiac function and patient outcomes. Genliva Wellness LLP supplies premium-quality Sacubitril + Valsartan Tablets for Advanced Heart Failure Management.

This formulation has become an important treatment option in modern cardiology for reducing hospitalization risk and improving quality of life in heart failure patients. As a reliable Heart Failure Medicine Manufacturer in India, Genliva Wellness LLP provides high-quality cardiovascular formulations to pharmaceutical companies and healthcare providers worldwide.

Manufactured using advanced pharmaceutical technologies and strict GMP standards, the product ensures consistent quality and therapeutic effectiveness. Genliva Wellness LLP is a trusted Global Supplier of Cardiology Medicines from India, offering export, contract manufacturing, and private-label solutions for international pharmaceutical markets.

Sacubitril + Valsartan Tablets are formulated to provide comprehensive heart failure management and cardiovascular support.

  • Combination of Sacubitril and Valsartan
  • Dual-action cardiovascular therapy
  • Supports improved cardiac function
  • Helps reduce cardiovascular stress
  • Suitable for long-term heart failure management

Sacubitril + Valsartan Tablets are used in the treatment and management of heart failure.

  • Chronic heart failure with reduced ejection fraction (HFrEF)
  • Cardiovascular risk reduction
  • Long-term heart failure therapy
  • Improvement of cardiac performance
  • Reduction of heart failure-related hospitalization

Sacubitril + Valsartan Tablets provide advanced cardiovascular support through complementary therapeutic mechanisms.

  • Helps improve heart function
  • Supports reduction in heart failure progression
  • Enhances long-term cardiovascular outcomes
  • Reduces risk of hospitalization
  • Widely accepted in modern cardiology practice
  • Available for export and private labeling

whatsapp-app